Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

3.80
Delayed Data
As of Dec 02
 +0.23 / +6.44%
Today’s Change
3.03
Today|||52-Week Range
7.18
-25.03%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for MabVax Therapeutics Holdings Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 18.00. The median estimate represents a +373.68% increase from the last price of 3.80.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in MabVax Therapeutics Holdings Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$6.36
Sales
$0.00
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -640.00%
 
 
 
 
 
Growthannually 72.45%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
Growthannually -88.32%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.